This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, Adverio Pharma Gmbh. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 12,268 
2 out of 387 
1 out of 22 Years Active: 2024-2026
Title: Helene Faber – Pioneering Innovations in Pharmaceutical Chemistry
Introduction
Helene Faber, an accomplished inventor based in Dormagen, Germany, has made significant contributions to the field of pharmaceutical chemistry. With a total of two patents to her name, her innovative work focuses on the development of novel processes for the preparation of pharmaceutically active compounds.
Latest Patents
Among her latest patents, Faber has developed a groundbreaking process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl][2-(2-{[3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms. This invention highlights a novel crystallization process for the preparation of different monohydrate forms, which are essential for treating various cardiopulmonary disorders. The patent emphasizes the inhalative treatment of conditions such as pulmonary arterial hypertension and chronic lung diseases, showcasing the pharmaceutical potential of her compounds.
Career Highlights
Helene Faber's professional journey includes significant roles at Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her work in these prestigious companies has allowed her to gain invaluable experience, further enhancing her innovative capabilities in pharmaceutical development.
Collaborations
Throughout her career, Faber has collaborated with esteemed colleagues such as Britta Olenik and Birgit Keil. These collaborations have facilitated knowledge exchange and the successful advancement of research projects in pharmaceutical chemistry.
Conclusion
Helene Faber's contributions to the field of pharmaceutical chemistry exemplify the spirit of innovation. Her patents, aimed at improving the treatment of complex cardiopulmonary disorders, reflect her commitment to developing effective medical solutions. As her career progresses, it will be intriguing to see how her work continues to impact the pharmaceutical industry and contributes to the betterment of health care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile